Plains GP Holdings LP
F:PG81
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Plains GP Holdings LP
F:PG81
|
US |
|
I
|
Innate Pharma SA
XBER:IDD
|
FR |
|
Orthex Oyj
F:4QU
|
FI |
|
D
|
Dexcom Inc
F:DC4
|
US |
|
S
|
Standard Motor Products Inc
F:SRU
|
US |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
|
C
|
Calbee Inc
F:9CB
|
JP |
|
F
|
First Western Financial Inc
F:33Q
|
US |
|
C
|
Camping World Holdings Inc
F:C83
|
US |
|
CSSC Hong Kong Shipping Co Ltd
F:3LL
|
HK |
|
Instalco AB
F:4IIA
|
SE |
|
Dexcom Inc
NASDAQ:DXCM
|
US |
|
R
|
RS Group PLC
DUS:ECN
|
UK |
|
H2APEX Group SCA
F:H2A
|
LU |
Wall St Price Targets
PG81 Price Targets Summary
Plains GP Holdings LP
According to Wall Street analysts, the average 1-year price target for PG81 is 10.71 EUR with a low forecast of 8.42 EUR and a high forecast of 12.64 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PG81's stock price target?
Price Target
10.71
EUR
According to Wall Street analysts, the average 1-year price target for PG81 is 10.71 EUR with a low forecast of 8.42 EUR and a high forecast of 12.64 EUR.
What is the Revenue forecast for Plains GP Holdings LP?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 4 years is 3%.
What is the Operating Income forecast for Plains GP Holdings LP?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 4 years is 15%.
What is the Net Income forecast for Plains GP Holdings LP?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 6 years is 11%.
